Pedrano, Mark Jhaydin .

HRN: 21-32-59  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2022
AMPICILLIN 500MG (VIAL)
05/11/2022
05/18/2022
IV
500mg
Q6
Pcap
Waiting Final Action 
05/12/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/12/2022
05/18/2022
IV
65mg
Q12 For 7 Days
Pneumonia
Waiting Final Action 
05/13/2022
AMOXICILLIN 100MG/ML, 10ML DROPS (BOT)
05/13/2022
05/19/2022
PO
2ml
3x A Day
PCAP C
Waiting Final Action 
05/13/2022
CEFUROXIME 750MG (VIAL)
05/13/2022
05/19/2022
IVT
330mg
Q8
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: